reference/8899146

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8899146

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	265
issn	1532-1827 0007-0920
issueIdentifier	3
pageRange	260-265
publicationName	British Journal of Cancer
startingPage	260
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a3faa600598d682b2adb331faf12c4fb http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a3b65a4365d3629293aa94bd01e2bad1
bibliographicCitation	Blackstock AW, Mornex F, Partensky C, Descos L, Case LD, Melin SA, Levine EA, Mishra G, Limentani SA, Kachnic LA, Tepper JE. Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. British Journal of Cancer. 2006 Jul 25;95(3):260–5. doi: 10.1038/sj.bjc.6603270.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca61e49f661209fadcc1281fa2829341 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30a2ad9a503641405d3b71275f374d6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_680edb05364d95309834e69fefe84204 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b02336da4daa08906f4bf72f86efa1c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48a7f8f9ba19b1fc2159faa43f2af6a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5626d92d481d4373b3a544e5f20daed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f221182aaff0c024219950d76b5df6eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9955752c6745215ab044a5e6555ebc78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cb1f5a758b383a6675f85302b14a020 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b74da5e18b19b651339d4c919df1fb5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c16c8a0a37e2cf24b5befc575055f273
date	2006-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/sj.bjc.6603270 https://pubmed.ncbi.nlm.nih.gov/16868545 https://pubmed.ncbi.nlm.nih.gov/PMC2360633
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765 https://portal.issn.org/resource/ISSN/1532-1827 https://portal.issn.org/resource/ISSN/0007-0920
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study
discusses	http://id.nlm.nih.gov/mesh/M000754277 http://id.nlm.nih.gov/mesh/M0005997
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129387307 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128288519

Total number of triples: 50.